PT2150514T - Folatos etiquetados com 18f - Google Patents

Folatos etiquetados com 18f

Info

Publication number
PT2150514T
PT2150514T PT08736121T PT08736121T PT2150514T PT 2150514 T PT2150514 T PT 2150514T PT 08736121 T PT08736121 T PT 08736121T PT 08736121 T PT08736121 T PT 08736121T PT 2150514 T PT2150514 T PT 2150514T
Authority
PT
Portugal
Prior art keywords
folates
labelled
labelled folates
Prior art date
Application number
PT08736121T
Other languages
English (en)
Inventor
Mensah Ametamey Simon
Moser Rudolf
Ludwig Ross Tobias
Groehn Viola
Original Assignee
Merck & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Cie filed Critical Merck & Cie
Publication of PT2150514T publication Critical patent/PT2150514T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
    • G01N23/02—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by transmitting the radiation through the material
    • G01N23/04—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by transmitting the radiation through the material and forming images of the material
    • G01N23/046—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by transmitting the radiation through the material and forming images of the material using tomography, e.g. computed tomography [CT]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Theoretical Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT08736121T 2007-04-11 2008-04-11 Folatos etiquetados com 18f PT2150514T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07105987 2007-04-11

Publications (1)

Publication Number Publication Date
PT2150514T true PT2150514T (pt) 2019-02-01

Family

ID=39578779

Family Applications (1)

Application Number Title Priority Date Filing Date
PT08736121T PT2150514T (pt) 2007-04-11 2008-04-11 Folatos etiquetados com 18f

Country Status (17)

Country Link
US (2) US9315506B2 (pt)
EP (1) EP2150514B1 (pt)
JP (1) JP5693950B2 (pt)
KR (1) KR101570452B1 (pt)
CN (2) CN104447750A (pt)
AU (1) AU2008237934B2 (pt)
CA (1) CA2670379C (pt)
DK (1) DK2150514T3 (pt)
EA (1) EA200901346A1 (pt)
ES (1) ES2707574T3 (pt)
HK (1) HK1207857A1 (pt)
IL (1) IL201249A (pt)
PL (1) PL2150514T3 (pt)
PT (1) PT2150514T (pt)
TR (1) TR201901010T4 (pt)
WO (1) WO2008125617A2 (pt)
ZA (1) ZA200903484B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2449774T3 (es) * 2007-04-11 2014-03-21 Merck & Cie Un método para la preparación de folatos marcados con 18F
CN102177160B (zh) 2008-10-10 2014-11-26 默克及其合伙人公司 作为pet放射性示踪剂的18f-标记叶酸
CN103732563B (zh) * 2011-08-22 2016-04-20 默克及其合伙人公司 18f-糖-叶酸类
CN104379585B (zh) * 2012-05-08 2018-07-06 默克及其合伙人公司 18f-标记的叶酸/抗叶酸剂类似物
US8906344B2 (en) * 2012-09-21 2014-12-09 Kasina Laila Innova Pharmaceuticals Private Limited F-18 radiolabeled compounds for diagnosing and monitoring kidney function
KR101646577B1 (ko) * 2014-08-14 2016-08-09 원광대학교산학협력단 엽산수용체 표적용 화합물 또는 이의 약학적으로 허용가능한 염과, 이를 유효성분으로 포함하는 암 예방, 진단 또는 치료용 조성물
US10039844B2 (en) * 2014-12-03 2018-08-07 The Board Of Trustees Of The Leland Stanford Junior University Imaging tumor glycolysis by non-invasive measurement of pyruvate kinase M2
JP7204662B2 (ja) * 2017-03-20 2023-01-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 異性体的に純粋な１８ｆ－標識されたテトラヒドロ葉酸

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2065653B (en) 1979-12-19 1983-03-09 Nat Res Dev Anti-cancer quinazoline derivatives
US4857530A (en) 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
US4871746A (en) 1988-05-31 1989-10-03 The Trustees Of Princeton University N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzoyl]glutamic acid derivatives as neoplastic growth inhibitors
GB9105771D0 (en) 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
EP0632038B1 (en) 1992-01-27 2001-08-22 Chugai Seiyaku Kabushiki Kaisha Methotrexate derivative
GB9205907D0 (en) 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
WO1999020626A1 (en) 1997-10-17 1999-04-29 Purdue Research Foundation Folic acid derivatives
WO2002076453A1 (en) 2001-03-27 2002-10-03 The University Of British Columbia Methods and compositions for photo-cross linking photoactive compounds to target tissue
DE60231868D1 (de) 2001-04-24 2009-05-20 Purdue Research Foundation Folat-mimetika und deren folatrezeptorbindende konjugate
WO2004069159A2 (en) 2003-01-27 2004-08-19 Endocyte, Inc. Vitamin receptor binding drug delivery conjugates
US20040259878A1 (en) * 2003-02-13 2004-12-23 Jason Koutcher Fluoromethotrexates and uses therefor
WO2006014706A2 (en) 2004-07-21 2006-02-09 Serenex, Inc. Methotrexate derivatives useful for treating cancer and arthritis
RU2007128036A (ru) 2004-12-23 2009-01-27 Пердью Рисерч Фаундейшн (Us) Способ получения изображения позитронно-эмиссионной томографией
CN1962658B (zh) 2005-11-10 2010-05-12 北京大学 一种四氢吡啶并[3,2-d]嘧啶类化合物及制备抗肿瘤药物的用途
WO2007098089A2 (en) 2006-02-17 2007-08-30 Novacea, Inc. Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
US20100226967A1 (en) 2006-05-23 2010-09-09 Purdue Research Foundation Imaging and therapeutic method using progenitor cells
KR101639268B1 (ko) * 2007-04-11 2016-07-13 메르크 앤드 씨에 １８ ｆ-표지된 폴레이트

Also Published As

Publication number Publication date
PL2150514T3 (pl) 2019-05-31
US9771368B2 (en) 2017-09-26
US9315506B2 (en) 2016-04-19
EP2150514B1 (en) 2018-10-24
WO2008125617A3 (en) 2009-06-25
EP2150514A2 (en) 2010-02-10
KR101570452B1 (ko) 2015-11-19
IL201249A0 (en) 2010-05-31
KR20090130110A (ko) 2009-12-17
HK1207857A1 (en) 2016-02-12
TR201901010T4 (tr) 2019-02-21
AU2008237934B2 (en) 2014-03-27
EA200901346A1 (ru) 2010-04-30
WO2008125617A2 (en) 2008-10-23
ES2707574T3 (es) 2019-04-04
CN101646670A (zh) 2010-02-10
IL201249A (en) 2016-03-31
JP2010526769A (ja) 2010-08-05
ZA200903484B (en) 2010-04-28
CN104447750A (zh) 2015-03-25
CA2670379C (en) 2015-06-23
AU2008237934A1 (en) 2008-10-23
CA2670379A1 (en) 2008-10-23
US20160159802A1 (en) 2016-06-09
US20100056533A1 (en) 2010-03-04
DK2150514T3 (en) 2019-02-18
JP5693950B2 (ja) 2015-04-01

Similar Documents

Publication Publication Date Title
HK1143162A1 (en) Polymorphe rotigotin-form
HK1139129A1 (en) 18f-labelled folates 18f-
AP2010005314A0 (en) Nanodispersian
IL201248A0 (en) 18f - labelled folates
HK1207857A1 (en) 18f-labelled folates 18f-
GB201009543D0 (en) Geothermiesystem
GB0708379D0 (en) Area-partitioning
GB2449333B (en) Appetite-control aid
GB2449050B (en) Shoping aid
GB2447030B (en) Fascines
GB0806623D0 (en) My leener
GB0713910D0 (en) Lensun
GB0701006D0 (en) Blankie bear
GB0701388D0 (en) Chair-moving aid
GB0715067D0 (en) Teching aid
GB0716646D0 (en) Switchsafe
GB0714378D0 (en) O-nin
GB0713852D0 (en) Toothslide
GB0713503D0 (en) Coolbreeze
GB0720468D0 (en) Multi-functional-folding-artist-palette
GB0716335D0 (en) Smart-connect
GB0707979D0 (en) Tic-tok-time-trainer-clock
GB0704722D0 (en) Respiritoir
GB0702333D0 (en) Negmattma
GB0702103D0 (en) Dynatags